NIH clinical trial of investigational vaccine for COVID-19 begins



The World Health Organization (WHO) has confirmed that the first vaccine trial for the Covid-19 virus has begun as the world continues to battle the growing pandemic.



In a media briefing on Wednesday, WHO chief Tedros Adhanom Ghebreyesus said the trial had commended “just 60 days after the genetic sequence of the coronavirus was shared.”

Tedros paid tribute to the “incredible achievement” of researchers around the world “who have come together to systemically evaluate experimental therapeutics.”

He said that “multiple small trials with different methods” may not result in the clear and strong evidence needed about which treatments save lives. The WHO and its partners are therefore organizing a large study across many countries to compare some untested treatments.

The study will be called the ‘Solidarity trial’ to reflect its unified nature.

“The Solidarity trial provides simplified procedures to enable even hospitals that have been overloaded to participate,” Tedros said, adding that countries including Argentina, Bahrain, Canada, France, Iran, Norway, South Africa, Spain, Switzerland and Thailand have already joined.

Post a Comment

0 Comments